Stay updated on CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.

Latest updates to the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedMinor editorial updates to the Publications section clarify that PubMed-sourced publications are auto-filled and may not relate to the study, and update the revision label from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoved a site-wide note about government funding status. The study details, eligibility criteria, and outcomes listed on the page remain unchanged.SummaryDifference0.3%

- Check49 days agoChange DetectedMinor layout and formatting updates observed on the page; core study details such as eligibility criteria, primary outcomes, study status, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check79 days agoChange DetectedMinor updates: capitalization fix for the condition name and a version bump to v3.1.0. No significant content or critical data changes detected.SummaryDifference0.2%

- Check86 days agoChange Detected- Updated date references and identifiers: added 2025-09-15, 2025-09-08, 2025-09, and an estimated last update line; replaced the EU CT Number formatting and its reference. - Removed earlier date references (2025-04-16, 2025-04-11) and the explicit older EU CT Number (2024-516894-57-00), plus the older “Last Update Posted” wording.SummaryDifference1.0%

Stay in the know with updates to CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.